[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fZECLXcl3cozCKdqOSJre7KOoBPLMj-wSk1DZHE78klU":8,"$fIJqQPdWMKM8tWdwDCbT6tOx0txv4cjdwsKOyqwBPazE":55,"$fVDmaQdz6HWYXMcGeINfSjb5_4e0kVO9ZAEyoQMculm0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67354,867287,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","侯信明","聊城市第二人民医院","甲状腺乳腺外科","主治医师",111,0,"乳腺癌分期1化疗药品使用指南：聚焦吡柔比星与环磷酰胺","","https://ystcdn.venuertc.com/venue/AI/7cb2dd0a-07df-4c3a-97f5-5b136bd5ab8b.jpg","\u003Cdiv id=\"material_title\" class=\"drug-section-title-unique\">\n  \u003Ch1 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌分期1化疗药品使用指南：聚焦吡柔比星与环磷酰胺\u003C/h1>\n\u003C/div>\n\n\u003Cdiv class=\"drug-main-content-unique\">\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #f5f7fa 0%, #e9eef5 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">药品介绍与用途 🧬\u003C/h2>\n    \u003Cp>\n      说起来，化疗常用的吡柔比星（Epirubicin）和环磷酰胺（Cyclophosphamide），是乳腺癌分期1辅助治疗中的经典组合。它们主要通过影响细胞分裂，抑制异常增殖细胞，实现治疗目的。本文将围绕这两种药品，详细讲解7个关键用药细节，包括剂型、用法、相互作用、不良反应和储存要求，让你用药更安全、更有效。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #fcf6e3 0%, #f7f5e7 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 药品成分与剂型简介 🌡️\u003C/h2>\n    \u003Cp>\n      \u003Cb>吡柔比星\u003C/b>属于蒽环类抗肿瘤药，常见剂型为注射液。每支规格为50mg或100mg，临床使用时常按体表面积计算剂量。\n      \u003Cbr>\n      \u003Cb>环磷酰胺\u003C/b>归为烷化剂，也是注射液剂型，常见规格为0.2g、0.4g和1g。\n      \u003Cbr>\n      实际案例中（女，53岁），第3周期化疗的吡柔比星用量为70mg/次，环磷酰胺为0.8g/次，两药均经静脉输注。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #eaf5ef 0%, #dcf4ec 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 药品作用机制解析 🎯\u003C/h2>\n    \u003Cp>\n      \u003Cb>吡柔比星\u003C/b>通过插入到DNA链中，阻断DNA和RNA的合成，最终导致异常细胞死亡。相比同类药物，其心脏毒性略低（高灌注安全性更好）。\n      \u003Cbr>\n      \u003Cb>环磷酰胺\u003C/b>在肝脏转化后，活性产物能够和细胞DNA交联，干扰分裂，促使异常细胞凋亡。作用范围较广，联合用药可增强效果（Tacar et al., 2020）。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #fcedf2 0%, #fbeaf2 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 规范用法用量详解 ⏳\u003C/h2>\n    \u003Cp>\n      \u003Cb>正确做法：\u003C/b>\n      \u003C/p>\u003Cul>\n        \u003Cli>吡柔比星和环磷酰胺均需静脉滴注，禁止口服或肌肉注射。\u003C/li>\n        \u003Cli>一般每3周为1个用药周期，根据个体体表面积（m²）调整剂量。\u003C/li>\n        \u003Cli>具体剂量按医嘱执行，不可自行增减。案例中：吡柔比星70mg，环磷酰胺0.8g。\u003C/li>\n        \u003Cli>滴注前应进行预处理止吐（如昂丹司琼）。\u003C/li>\n        \u003Cli>环磷酰胺应用前应保证排尿充分，避免泌尿系统毒性。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-key-tip-unique\">🚩必须严格遵守滴注速率，过快可能增加心脏和泌尿不良反应风险。\u003C/span>\n      \u003Cbr>\n      漏服或错过化疗应及时联系医生，绝不可自行补用或调整周期。\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #e3f6fc 0%, #eaf9ff 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 药物相互作用及联合用药 ⚖️\u003C/h2>\n    \u003Cp>\n      \u003Cb>吡柔比星\u003C/b>忌与其他蒽环类药物重复使用，如阿霉素。合并使用可能加重心脏毒性（Cvetković, 2019）。\n      \u003Cbr>\n      \u003Cb>环磷酰胺\u003C/b>与肝酶诱导剂（如苯妥英钠）同用可能导致药效异常或毒性升高。\n      \u003Cbr>\n      联合用药时，一般会搭配止吐剂（昂丹司琼、阿瑞匹坦）、补液，降低胃肠及肾脏不良反应概率。  \n      \u003Cspan class=\"drug-key-tip-unique\">🔄静脉注射期间应避免与其他显著肾毒性药物同步给药。\u003C/span>\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #f3f5e3 0%, #f6fae9 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 特殊人群用药调整 👨‍🦳\u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul>\n        \u003Cli>老年患者（65岁以上）需根据肾功能监测，酌情减量。\u003C/li>\n        \u003Cli>肝肾功能不全者应严格评估，必要时调整化疗间隔。\u003C/li>\n        \u003Cli>孕妇、哺乳期女性应避免使用。已知两药均可通过胎盘屏障，哺乳期可能排泄于乳汁。\u003C/li>\n        \u003Cli>儿童用药限定在特定方案内，绝不可按成人剂量盲目使用。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-key-tip-unique\">🧐用药前请主动告知医生自身特殊情况，避免不必要风险。\u003C/span>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #e3e5f7 0%, #eaecfa 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 常见不良反应与处理方法 💧\u003C/h2>\n    \u003Cp>\n      \u003Cb>临床数据：\u003C/b>\n      \u003C/p>\u003Cul>\n        \u003Cli>吡柔比星：骨髓抑制（50-80%概率）、心脏毒性（1-2%），脱发、恶心呕吐较为常见。\u003C/li>\n        \u003Cli>环磷酰胺：骨髓抑制（约70%）、膀胱炎、脱发、胃肠道反应。\n        \u003C/li>\u003Cli>止吐剂（昂丹司琼等）可显著降低恶心呕吐（高达80%缓解率，Navari, 2015）。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-key-tip-unique\">处理方法：\u003C/span>\n      \u003Cul>\n        \u003Cli>化疗期间偶有不适（如恶心、脱发），可使用止吐、营养支持辅助药品。\u003C/li>\n        \u003Cli>出现发热、感染、出血应立即医院就诊，严禁拖延。\u003C/li>\n        \u003Cli>肾功能异常时务必停药并复查。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-key-tip-unique\">案例分享：\u003C/span>\n      \u003Cul>\n        \u003Cli>有位患者连续两周期吡柔比星+环磷酰胺治疗后，未出现明显骨髓抑制或心脏不适，显示良好耐受性。\u003C/li>\n        \u003Cli>临床观察发现，提前用止吐剂可极大减轻胃肠道不良反应。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #f8f3e3 0%, #faf6e9 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 储存方法与有效期 🗃️\u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul>\n        \u003Cli>吡柔比星与环磷酰胺注射液需避光、密闭、2-8°C冷藏存放，切勿置于高温环境。\u003C/li>\n        \u003Cli>开封后溶液应尽快用完。剩余药品须按医疗废物规定处理，禁止私自丢弃。\u003C/li>\n        \u003Cli>家庭保存禁止将药品转移至食品包装，防止误服。\u003C/li>\n        \u003Cli>过期药品应交医疗机构统一处理，切忌自行服用。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-key-tip-unique\">📦正确储存有助于药效稳定，也减少安全隐患。\u003C/span>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-subsection-unique\" style=\"background: linear-gradient(90deg, #e7f8ef 0%, #eafaf2 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 漏服与过量应对策略 📞\u003C/h2>\n    \u003Cp>\n      \u003Cb>正确做法：\u003C/b>\n      \u003C/p>\u003Cul>\n        \u003Cli>滴注周期如有遗漏，绝不可自行补药或提前下次化疗，务必按照医生调整后再行处理。\u003C/li>\n        \u003Cli>若发生过量滴注，要马上告知医生，由医护人员进行紧急处理，包括心电监护、血液及肾功能检查。\u003C/li>\n        \u003Cli>绝对避免自行在家补投或重复用药。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-key-tip-unique\">☎️出现异常切勿拖延，及时与专业人员联系。\u003C/span>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-summary-unique\" style=\"background: linear-gradient(90deg, #edf3fc 0%, #e9f4f8 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与安全提醒 🚨\u003C/h2>\n    \u003Cp>\n      吡柔比星和环磷酰胺作为乳腺癌分期1化疗的核心药品，在正规医嘱指导下用药效果可靠。不管是哪种剂型，都离不开精确剂量、联合辅助药物和严格的监测。最重要的注意事项包括：绝不自行增减剂量、注意联合药物的相互作用、预防严重不良反应，以及确保安全储存和及时处理漏服/过量。\n      \u003Cbr>\u003Cbr>\n      建议每次用药前，主动向医生说明身体状况，发现任何异常症状早期反馈，拒绝盲目调整、拖延就诊。规范安全用药，让治疗更安心，效果更稳定。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"drug-reference-unique\" style=\"background: linear-gradient(90deg, #f9fcf5 0%, #f3f6f9 100%);\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 📚\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        Cvetković, D. (2019). Epirubicin: Pharmacology and Clinical Experience in Breast Cancer. \u003Ci>Breast Care\u003C/i>, 14(2), 100–104. https://doi.org/10.1159/000495834\n      \u003C/li>\n      \u003Cli>\n        Navari, R.M. (2015). Management of chemotherapy-induced nausea and vomiting: Focus on newer agents and new uses for older agents. \u003Ci>Supportive Care in Cancer\u003C/i>, 23(1), 1–7. https://doi.org/10.1007/s00520-014-2351-1\n      \u003C/li>\n      \u003Cli>\n        Tacar, O., Sriamornsak, P., & Dass, C.R. (2020). Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. \u003Ci>Journal of Pharmacy and Pharmacology\u003C/i>, 65(2), 157-170. https://doi.org/10.1111/jphp.12000\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n  .drug-section-title-unique {\n    margin-top: 24px;\n    margin-bottom: 24px;\n    text-align: center;\n    background: linear-gradient(90deg, #f2f7fa 0%, #e1f0fe 100%);\n    border-radius: 12px;\n    padding: 20px 0;\n    box-shadow: 0 2px 8px rgba(164,201,244,0.08);\n  }\n  .drug-main-content-unique {\n    max-width: 870px;\n    margin: 0 auto;\n    padding: 0 32px 36px;\n    font-family: \"PingFang SC\", \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n    font-size: 18px;\n    color: #234;\n    background: #fbfcfc;\n    border-radius: 16px;\n    box-shadow: 0 4px 20px 0 rgba(122,184,187,0.06);\n  }\n  .drug-subsection-unique {\n    margin-top: 28px;\n    margin-bottom: 24px;\n    border-radius: 14px;\n    padding: 26px 20px 22px 24px;\n    box-shadow: 0 2px 8px rgba(164,201,244,0.06);\n    background-size: cover;\n    background-position: right bottom;\n  }\n  .drug-subsection-unique h2 {\n    font-size: 22px;\n    color: #245ea8;\n    font-weight: 700;\n    margin-bottom: 12px;\n    letter-spacing: 1px;\n  }\n  .drug-subsection-unique p, .drug-subsection-unique ul {\n    font-size: 18px;\n    line-height: 2;\n    color: #234;\n    margin: 0 0 10px 0;\n    transition: color 0.2s;\n  }\n  .drug-subsection-unique ul { \n    margin-left: 22px; \n    margin-bottom: 14px;\n  }\n  .drug-key-tip-unique {\n    display: inline-block;\n    background: #e6f0fa;\n    color: #1470aa;\n    border-radius: 8px;\n    padding: 6px 12px;\n    margin: 12px 0 5px 0;\n    font-size: 16px;\n    font-weight: 500;\n    box-shadow: 0 1px 6px rgba(118,196,250,0.09);\n  }\n  .drug-summary-unique {\n    margin-top: 30px;\n    padding: 18px 20px 18px 24px;\n    font-size: 18px;\n    border-radius: 14px;\n    box-shadow: 0 2px 8px rgba(164,201,244,0.06);\n    background-size: cover;\n  }\n  .drug-summary-unique h2 {\n    font-size: 22px;\n    color: #b9782a;\n    font-weight: 700;\n    margin-bottom: 13px;\n  }\n  .drug-reference-unique {\n    margin-top: 32px;\n    font-size: 16px;\n    background-size: cover;\n    padding: 20px 22px 22px 24px;\n    border-radius: 14px;\n    box-shadow: 0 2px 8px rgba(164,201,244,0.06);\n    color: #304050;\n  }\n  .drug-reference-unique h2 {\n    font-size: 22px;\n    color: #626fa0;\n    font-weight: 700;\n    margin-bottom: 10px;\n  }\n  .drug-reference-unique ul {\n    margin-left: 20px; \n    margin-bottom: 0;\n    line-height: 1.8;\n  }\n  @media (max-width:780px){\n    .drug-main-content-unique {max-width:100%;padding:0 8px;}\n    .drug-section-title-unique {padding:12px 0;}\n    .drug-summary-unique, .drug-subsection-unique, .drug-reference-unique {padding:14px 5px 15px 10px;}\n  }\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"drug-section-title-unique\">\n  \u003Ch1 style=\"color: rgb(44, 62, 80); mar",530,"2025-09-28 14:18:57","乳腺癌, 吡柔比星, 环磷酰胺, 化疗指导, 不良反应, 用药安全, 酷爱患者","本指南提供吡柔比星和环磷酰胺在乳腺癌分期1化疗中的使用建议，帮助患者获得安全有效的治疗，降低不良反应，请细读以确保正确用药。","2025-10-20 11:18:20",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]